Trial
NCT03426345
Study to Evaluate the Safety and Efficacy of Relamorelin in Participants With Diabetic Gastroparesis Study 02
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Allergan
Collaborators
—
Condition
Gastroparesis
Intervention
Placebo
Why stopped
The Relamorelin program is being terminated solely based on a business decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-08-06